TH124A - Units of medication - Google Patents

Abstract

This proposed invention involves shaping a drug unit—a medication to be administered orally—in a manner that, when placed on a flat surface, it remains in an inclined position with maximum stability. The advantage of this type of drug unit is its ease of handling. The unit can be manufactured by shaping the active ingredient along with other necessary additional components into a predetermined form.

Claims (22)

1. The process for preparing bonded drug units results in a shape that, when placed on a flat surface, ensures maximum stability, ideally at an angle of inclination to the surface, with the minimum angle being 6 degrees. This involves shaping the active ingredient along with other necessary non-drug components into this form. 2. The process referred to in Claim 1 relating to drug units with a principal shape and a pivot point formed by one or more protrusions from the principal shape. 3. The process as claimed in claim 2, relating to the protruding part, is a button. 4. The process referred to in Claim 3 relating to cube-shaped buttons, solid rectangular bars, pyramids, or spherical curves. 5. The process as referred to in claim 4, where the button is shaped like a triangular pyramid, a square pyramid, or a pentagonal pyramid. 6. The process as claimed in claim 3 relating to the rounding of the button. 7. The process referred to in Claim 4 concerning rounded buttons is cut into one, two, three, or four faceted planes. 8. The process as referred to in claim 4, where the button is a curved, circular shape. 9. The process as referred to in claim 2, where the protruding part is convex. 10. The process referred to in any of the claims in Claims 2 through 9 concerning basic shapes has the longest principal shape dimension and two shorter principal shape dimensions. 11. The procedure as referred to in claim 10, where the dimensions of the two short principal shapes are equal. 12. The process as referred to in Claims 10 and 11, where the primary form of the drug unit is a capsule. 13. The process referred to in any of the claims in Claims 10 through 12 states that the ratio of the longest principal shape dimension to the shortest principal shape dimension is in the range of 2.5 to 1 to 3.5 to 1. 14. The process as referred to in any of the claims in Claims 2 through 9, whereby the basic shape of the unit of medicine has two principal shape dimensions of the longest and one principal shape dimension of the shortest. 15. The process as referred to in claim 14, whereby the shape of the drug unit is an upright cylinder. 16. The process referred to in claim 15 states that the ratio of the shortest principal dimension to the longest principal dimension is between 1:2 and 1:3.5. 17. The process as referred to in claim 14, where the basic shape of the drug unit is a rectangular bar. 18. The process referred to in claim 17, where the ratio of the shortest principal dimension to the longest principal dimension is between 1 to 2 and 1 to 3.5. 19. The process referred to in any of the claims in Claims 2 through 18, where the edges or corners of the basic shape are rounded or beveled. 20. The process referred to in Claim 17 or Claim 18, concerning the rounding of the corners connecting the largest surfaces of a parallelogram, 21. The process as referred to in any of the claims in Claims 1 through 20, where the drug unit is in the form of a tablet. 22. The process as referred to in any one of the claims in Claims 1 through 21, where the forming of the drug unit involves the compression of the active ingredient and other necessary substances with a tablet press and a die (Claims 22, 2 pages, 30 figures).